Board of Directors Approves Increase in Quarterly Cash Dividend to $0.30 Per Share
The board of directors of Pfizer Inc. today declared a 30-cent first-quarter 2016 dividend on the company’s common stock, payable March 2, 2016, to shareholders of record at the close of business on February 5, 2016. Pfizer increased the dividend by approximately 7 percent, to 30 cents from 28 cents per share.
The first-quarter 2016 cash dividend will be the 309th consecutive quarterly dividend paid by Pfizer.
“The dividend increase is a testament to our continued commitment to enhancing shareholder value and our confidence in the business,” stated Ian Read, Pfizer chairman and chief executive officer. “As always, we are focused on maximizing total shareholder return, of which the dividend remains a key component.”
Pfizer fa parte del gruppo “Health Care” del portafoglio Black Dog.
Ad oggi l’investimento in Pfizer ha restituito 48.1 euro che corrispondono ad un tasso di payback del 4.57%.
Il nuovo dividend yeld netto “on cost” si attesta al 2.53% e al 2.65% considerando i dividendi già incassati.
Ad oggi l’investimento in Pfizer corrisponde al 1.8% dell’intero portafoglio.